Transplantation tolerance: the big picture. Where do we stand, where should we go?
A major goal in organ transplantation has been to safely exploit the natural processes of immune tolerance in order to minimize the dose and duration of drug immunosuppression. In this commentary, I argue that we can learn from how tumours avoid rejection, to evolve a three-stage tolerance-inducing...
Päätekijä: | Waldmann, H |
---|---|
Aineistotyyppi: | Journal article |
Kieli: | English |
Julkaistu: |
Wiley
2017
|
Samankaltaisia teoksia
-
Transplantation tolerance-where do we stand?
Tekijä: Waldmann, H
Julkaistu: (1999) -
Mesenchymal Stromal Cells’ Therapy for Polyglutamine Disorders: Where Do We Stand and Where Should We Go?
Tekijä: Inês Barros, et al.
Julkaistu: (2020-10-01) -
Osteoarthritis and Diabetes: Where Are We and Where Should We Go?
Tekijä: Aqeel M. Alenazi, et al.
Julkaistu: (2023-04-01) -
ColVI myopathies: where do we stand, where do we go?
Tekijä: Allamand Valérie, et al.
Julkaistu: (2011-09-01) -
Training Needs Assessment: Where We Are and Where We Should Go
Tekijä: Rodrigo Rezende Ferreira, et al.
Julkaistu: (2013-01-01)